Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207345 Oxygenase enzymes and screening method
11/06/2003US20030207343 Method for determining the anticoagulatory potential of a sample
11/06/2003US20030207342 Without the separation of components of a sample; using cholesterol esterase and either cholesterol oxidase or cholesterol dehydrogenase, with phospholipase and measuring amount of hydrogen peroxide or reduced coenzyme formed
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207340 For diagnosis of cancer
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207335 For preparation of kits and biosensors for disease diagnosis and compound analyses
11/06/2003US20030207328 Analyte assay using particulate labels
11/06/2003US20030207327 Eukaryotic cells engineered to differ by as few as one encoded amino acid at a defined target locus; for therapeutic and pharmacogenic use
11/06/2003US20030207326 Methods and device for biomolecule characterization
11/06/2003US20030207325 Methods for identifying agents which alter histone protein acetylation, decrease aging, increase lifespan
11/06/2003US20030207323 5'-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
11/06/2003US20030207321 Nucleic acid fragments for the identification of bacteria in industrial wastewater bioreactors
11/06/2003US20030207320 Diagnostic for organisms key to health of activated sludge wastewater systems
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207317 Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/06/2003US20030207316 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/06/2003US20030207315 Anti-aging nucleic acid and protein targets
11/06/2003US20030207314 Determining the probable surname of a male from a sample of his tissue or DNA, wherein the haplotype of his sample is compared with a database, the database containing information which correlates Y chromosome haplotypes to given surnames
11/06/2003US20030207312 Gene monitoring and gene identification using cDNA arrays
11/06/2003US20030207311 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/06/2003US20030207310 System and method for determining the sizes and quantity of polynucleotides with capillary array electrophoresis
11/06/2003US20030207309 Diagnostics and therapeutics for macular degeneration-related disorders
11/06/2003US20030207307 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke
11/06/2003US20030207306 By hybridizing an oligonucleotide containing the tag to a population of nucleic acids, separating hybridizing bound oligonucleotides, and then removing and identifying the tag
11/06/2003US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
11/06/2003US20030207304 Glycerol-doped aerogel coatings as biological capture media
11/06/2003US20030207303 Method and kit for determining human geographic or population origin
11/06/2003US20030207302 Universal probe system
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207300 Multiplex analytical platform using molecular tags
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207298 Method for detecting target plant genus
11/06/2003US20030207297 Involves creating a database of genomic samples from healthy human donors; use of the database to identify and correlate with polymorphic genetic markers and other markers with diseases and conditions
11/06/2003US20030207296 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/06/2003US20030207295 Used in genotyping, detection and quantification of a nucleic acid target using amplification techniques; applications can include the use of adapter sequences to allow for universal arrays
11/06/2003US20030207294 Method for analysing immunodeficiency virus (HIV) phenotypic characteristics
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207292 Method of amplifying nucleic acid by using double-stranded nucleic acid as template
11/06/2003US20030207290 Methods, reagents, kits and apparatus for protein function analysis
11/06/2003US20030207289 Using additional amplification molecules to enhance the detectable signal
11/06/2003US20030207287 Non-stochastic generation of genetic vaccines
11/06/2003US20030207285 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing prognosing disorders related to the polypeptides
11/06/2003US20030207284 Genotypes, haplotypes, and haplotype pairs of the Uncoupling Protein 2 (UCP2) gene
11/06/2003US20030207282 Method to amplify variable sequences without imposing primer sequences
11/06/2003US20030207281 Genetic variants of the Chemokine Receptor 4 (CXCR4) gene are described; Compositions and methods for haplotyping and/or genotyping the CXCR4 gene
11/06/2003US20030207280 Substrate with detection agents for determining expression levels of a plurality of genes; combination of weighted expression levels of the genes is indicative of a physiological condition defined in traditional Chinese
11/06/2003US20030207279 Using polymerase chain reaction
11/06/2003US20030207277 Human deoxyguanosine kinase (dGK) variants associated with cancers
11/06/2003US20030207276 For diagnosis
11/06/2003US20030207275 For molecular diagnosis
11/06/2003US20030207274 Human NjmuR1-related gene variant associated with lung cancers
11/06/2003US20030207273 Polynucleotide primers and probes for rapid detection of Group B streptococcal (GBS)
11/06/2003US20030207272 Composition and methods for detection of von willebrand's disease
11/06/2003US20030207271 Methods and compositions for biological sensors
11/06/2003US20030207270 For creating, maintaining, improving and utilizing Herbal BioResponse Arrays (HBR Arrays); for standardization of herbal compositions
11/06/2003US20030207269 High throughput gene expression for drug discovery
11/06/2003US20030207268 Methods for the diagnosis and prognosis of acute leukemias
11/06/2003US20030207267 Multiply-primed amplification of nucleic acid sequences
11/06/2003US20030207266 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures
11/06/2003US20030207265 For assessing structure or function
11/06/2003US20030207264 Use of a single fluorophore rather than an "acceptor-donor" fluoresecence resonance energy transfer system offers synthesis and performance advantages; fluorogenic protease indicators
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207260 Contacted with probe that hybridizes one complementary sequence
1 ... 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 ... 3003